Validation of the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival

Journal of Heart and Lung Transplantation

Volumn 31, Issue 11, 2012, Pages 1165-1170

  Cogswell, Rebecca ^a   Kobashigawa, Erin ^a   McGlothlin, Dana ^a   Shaw, Robin ^a   De Marco, Teresa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

pulmonary arterial hypertension; REVEAL model; survival; survival prediction

Indexed keywords

ADULT; AGED; ARTICLE; EXTERNAL VALIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM SURVIVAL; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL PREDICTION;

ADULT; AGED; COMORBIDITY; DISEASE MANAGEMENT; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; MALE; METHAMPHETAMINE; MIDDLE AGED; MODELS, STATISTICAL; REGISTRIES; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; SURVIVAL RATE; TIME FACTORS;

EID: 84867544301     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.08.009     Document Type: Article

References (20)

1. H.W. Farber, J. Loscalzo Pulmonary arterial hypertension N Engl J Med 351 2004 1655 1665
2. O. Sitbon, M. Humbert, H. Nunes et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival J Am Coll Cardiol 40 2002 780 788
3. G.E. D'Alonzo, R.J. Barst, S.M. Ayres et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med 115 1991 343 349
4. M. Humbert, O. Sitbon, A. Chaouat et al. Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 2006 1023 1030
5. R. Badagliacca, B. Pezzuto, R. Poscia et al. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral J Heart Lung Transplant 31 2012 364 372
6. N. Galie, A. Manes, L. Negro, M. Palazzini, M.L. Bacchi-Reggiani, A. Branzi A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 30 Feb 2009 394 403
7. R.L. Benza, D.P. Miller, A. Frost, R.J. Barst, A.M. Krichman, M.D. McGoon Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry Transplantation 90 2010 298 305
8. R.L. Benza, D.P. Miller, M. Gomberg-Maitland et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 2010 164 172
9. R.L. Benza, M. Gomberg-Maitland, D.P. Miller et al. The REVEAL registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension Chest 141 2012 354 362
10. G.C. Kane, H. Maradit-Kremers, J.P. Slusser, C.G. Scott, R.P. Frantz, M.D. McGoon Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension Chest 139 2011 1285 1293
11. S.E. Bleeker, H.A. Moll, E.W. Steyerberg et al. External validation is necessary in prediction research: a clinical example J Clin Epidemiol 56 2003 826 832
12. E.W. Steyerberg, S.E. Bleeker, H.A. Moll, D.E. Grobbee, K.G. Moons Internal and external validation of predictive models: a simulation study of bias and precision in small samples J Clin Epidemiol 56 2003 441 447
13. D. Giavarina, D.N. Cruz, G. Soffiati, C. Ronco Comparison of estimated glomerular filtration rate (eGFR) using the MDRD and CKD-EPI equations for CKD screening in a large population Clin Nephrol 74 2010 358 363
14. M.D. McGoon, A. Krichman, H.W. Farber et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension Mayo Clin Proc 83 2008 923 931
15. C.H. Hsu, C. Glassner, A.J. Foreman et al. Treadmill testing improves survival prediction models in pulmonary arterial hypertension Am Heart J 162 2011 1011 1017
16. Clark T, Marquez C, Hare CB, John MD, Klausner JD Methamphetamine use, transmission risk behavior and internet use among HIV-infected patients in medical care, San Francisco, 2008. AIDS Behav 2012;16:396-403.
17. T. Thenappan, S.J. Shah, S. Rich, L. Tian, S.L. Archer, M. Gomberg-Maitland Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation Eur Respir J 35 2010 1079 1087
18. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-1619.
19. F.S. Resnic, L. Ohno-Machado, A. Selwyn, D.I. Simon, J.J. Popma Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention Am J Cardiol 88 2001 5 9
20. B. Ley, C.J. Ryerson, E. Vittinghoff et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis Ann Intern Med 156 2012 684 691